348 related articles for article (PubMed ID: 10215618)
21. Structural determinants of heparan sulfate interactions with Slit proteins.
Zhang F; Ronca F; Linhardt RJ; Margolis RU
Biochem Biophys Res Commun; 2004 Apr; 317(2):352-7. PubMed ID: 15063764
[TBL] [Abstract][Full Text] [Related]
22. A new sequencing approach for N-unsubstituted heparin/heparan sulfate oligosaccharides.
Liang QT; Xiao XM; Lin JH; Wei Z
Glycobiology; 2015 Jul; 25(7):714-25. PubMed ID: 25677303
[TBL] [Abstract][Full Text] [Related]
23. Analytical and preparative strong anion-exchange HPLC of heparan sulfate and heparin saccharides.
Turnbull JE
Methods Mol Biol; 2001; 171():141-7. PubMed ID: 11450224
[No Abstract] [Full Text] [Related]
24. Applications of heparin and heparan sulfate microarrays.
Yin J; Seeberger PH
Methods Enzymol; 2010; 478():197-218. PubMed ID: 20816481
[TBL] [Abstract][Full Text] [Related]
25. Structural specificity in a FGF7-affinity purified heparin octasaccharide required for formation of a complex with FGF7 and FGFR2IIIb.
Luo Y; Ye S; Kan M; McKeehan WL
J Cell Biochem; 2006 Apr; 97(6):1241-58. PubMed ID: 16315317
[TBL] [Abstract][Full Text] [Related]
26. Online reverse phase-high-performance liquid chromatography-fluorescence detection-electrospray ionization-mass spectrometry separation and characterization of heparan sulfate, heparin, and low-molecular weight-heparin disaccharides derivatized with 2-aminoacridone.
Galeotti F; Volpi N
Anal Chem; 2011 Sep; 83(17):6770-7. PubMed ID: 21780812
[TBL] [Abstract][Full Text] [Related]
27. Preparation and use of microarrays containing synthetic heparin oligosaccharides for the rapid analysis of heparin-protein interactions.
Noti C; de Paz JL; Polito L; Seeberger PH
Chemistry; 2006 Nov; 12(34):8664-86. PubMed ID: 17066397
[TBL] [Abstract][Full Text] [Related]
28. Octasaccharide is the minimal length unit required for efficient binding of cyclophilin B to heparin and cell surface heparan sulphate.
Vanpouille C; Denys A; Carpentier M; Pakula R; Mazurier J; Allain F
Biochem J; 2004 Sep; 382(Pt 2):733-40. PubMed ID: 15109301
[TBL] [Abstract][Full Text] [Related]
29. Heparin sequencing using enzymatic digestion and ESI-MSn with HOST: a heparin/HS oligosaccharide sequencing tool.
Saad OM; Leary JA
Anal Chem; 2005 Sep; 77(18):5902-11. PubMed ID: 16159120
[TBL] [Abstract][Full Text] [Related]
30. Chromatographic analysis and sequencing approach of heparin oligosaccharides using cetyltrimethylammonium dynamically coated stationary phases.
Mourier PA; Viskov C
Anal Biochem; 2004 Sep; 332(2):299-313. PubMed ID: 15325299
[TBL] [Abstract][Full Text] [Related]
31. Integral glycan sequencing of heparan sulfate and heparin saccharides.
Turnbull JE
Methods Mol Biol; 2001; 171():129-39. PubMed ID: 11450223
[No Abstract] [Full Text] [Related]
32. A defect in exodegradative pathways provides insight into endodegradation of heparan and dermatan sulfates.
Fuller M; Chau A; Nowak RC; Hopwood JJ; Meikle PJ
Glycobiology; 2006 Apr; 16(4):318-25. PubMed ID: 16377754
[TBL] [Abstract][Full Text] [Related]
33. Production of size-defined heparosan, heparan sulfate, and heparin oligosaccharides by enzymatic depolymerization.
Brown S; Kuberan B
Methods Mol Biol; 2015; 1229():21-9. PubMed ID: 25325940
[TBL] [Abstract][Full Text] [Related]
34. Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences.
Hecht ML; Rosental B; Horlacher T; Hershkovitz O; De Paz JL; Noti C; Schauer S; Porgador A; Seeberger PH
J Proteome Res; 2009 Feb; 8(2):712-20. PubMed ID: 19196184
[TBL] [Abstract][Full Text] [Related]
35. Heparan sulfate-protein interactions: therapeutic potential through structure-function insights.
Coombe DR; Kett WC
Cell Mol Life Sci; 2005 Feb; 62(4):410-24. PubMed ID: 15719168
[TBL] [Abstract][Full Text] [Related]
36. An approach for separation and complete structural sequencing of heparin/heparan sulfate-like oligosaccharides.
Huang R; Liu J; Sharp JS
Anal Chem; 2013 Jun; 85(12):5787-95. PubMed ID: 23659663
[TBL] [Abstract][Full Text] [Related]
37. Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.
Loo BM; Kreuger J; Jalkanen M; Lindahl U; Salmivirta M
J Biol Chem; 2001 May; 276(20):16868-76. PubMed ID: 11278860
[TBL] [Abstract][Full Text] [Related]
38. Semi-synthetic heparin derivatives: chemical modifications of heparin beyond chain length, sulfate substitution pattern and N-sulfo/N-acetyl groups.
Fernández C; Hattan CM; Kerns RJ
Carbohydr Res; 2006 Jul; 341(10):1253-65. PubMed ID: 16712822
[TBL] [Abstract][Full Text] [Related]
39. Insights into the mechanism of separation of heparin and heparan sulfate disaccharides by reverse-phase ion-pair chromatography.
Jones CJ; Membreno N; Larive CK
J Chromatogr A; 2010 Jan; 1217(4):479-88. PubMed ID: 20004903
[TBL] [Abstract][Full Text] [Related]
40. Heparan sulphate: a heparin in miniature.
Gallagher JT
Handb Exp Pharmacol; 2012; (207):347-60. PubMed ID: 22566232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
